IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 244 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $60,605 | -65.7% | 13,320 | -46.9% | 0.00% | – |
| Q2 2023 | $176,695 | -82.6% | 25,099 | -84.9% | 0.00% | -100.0% |
| Q1 2023 | $1,017,911 | +252.8% | 166,598 | +268.9% | 0.00% | +100.0% |
| Q4 2022 | $288,558 | +56.8% | 45,158 | +132.7% | 0.00% | – |
| Q3 2022 | $184,000 | -35.2% | 19,407 | -25.0% | 0.00% | -100.0% |
| Q2 2022 | $284,000 | +2084.6% | 25,864 | +2997.5% | 0.00% | – |
| Q1 2022 | $13,000 | -95.5% | 835 | -92.5% | 0.00% | – |
| Q2 2021 | $287,000 | -57.5% | 11,073 | -48.2% | 0.00% | -100.0% |
| Q1 2021 | $675,000 | +33.1% | 21,364 | +95.2% | 0.00% | 0.0% |
| Q4 2020 | $507,000 | +40.8% | 10,944 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $360,000 | -78.7% | 10,944 | -82.2% | 0.00% | -75.0% |
| Q2 2020 | $1,689,000 | -33.3% | 61,574 | -27.3% | 0.00% | -42.9% |
| Q1 2020 | $2,534,000 | +7.9% | 84,689 | -0.2% | 0.01% | +75.0% |
| Q4 2019 | $2,348,000 | +166.8% | 84,872 | +75.5% | 0.00% | +100.0% |
| Q3 2019 | $880,000 | +576.9% | 48,352 | +189.0% | 0.00% | – |
| Q3 2017 | $130,000 | -65.8% | 16,732 | -67.7% | 0.00% | -100.0% |
| Q2 2017 | $380,000 | – | 51,761 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 565,890 | $26,257,000 | 9.39% |
| Consonance Capital Management LP | 1,710,803 | $79,381,000 | 7.41% |
| GREAT POINT PARTNERS LLC | 917,427 | $42,569,000 | 6.91% |
| Avoro Capital Advisors LLC | 7,500,000 | $348,000,000 | 5.99% |
| Ghost Tree Capital, LLC | 500,000 | $23,200,000 | 5.17% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $60,923,000 | 4.69% |
| Perceptive Advisors | 9,166,304 | $425,316,000 | 4.56% |
| Ally Bridge Group (NY) LLC | 360,000 | $16,704,000 | 2.86% |
| Orbimed Advisors | 6,645,100 | $308,333,000 | 2.70% |
| ACUTA CAPITAL PARTNERS, LLC | 164,800 | $7,647,000 | 2.08% |